(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $23.63
发出时间: 14 Feb 2024 @ 22:30
回报率: 8.21%
上一信号: Feb 13 - 22:30
上一信号:
回报率: 0.60 %
Live Chart Being Loaded With Signals
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally...
Stats | |
---|---|
今日成交量 | 35 968.00 |
平均成交量 | 80 309.00 |
市值 | 379.71M |
EPS | $0 ( 2024-03-13 ) |
下一个收益日期 | ( $-0.190 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.53 |
ATR14 | $0.0420 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Levitz Michael L | Buy | 51 682 | Stock Option (Right to Buy) |
2024-03-15 | Levitz Michael L | Buy | 21 329 | Restricted Stock Unit |
2024-03-15 | Colleran David | Buy | 46 875 | Stock Option (Right to Buy) |
2024-03-15 | Colleran David | Buy | 19 345 | Restricted Stock Unit |
2024-03-15 | Nunes Anne | Buy | 26 442 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
51.59 |
Last 100 transactions |
Buy: 1 044 875 | Sell: 338 384 |
音量 相关性
Anika Therapeutics Inc 相关性 - 货币/商品
Anika Therapeutics Inc 财务报表
Annual | 2023 |
营收: | $166.66M |
毛利润: | $103.09M (61.85 %) |
EPS: | $-5.64 |
FY | 2023 |
营收: | $166.66M |
毛利润: | $103.09M (61.85 %) |
EPS: | $-5.64 |
FY | 2022 |
营收: | $156.24M |
毛利润: | $93.58M (59.89 %) |
EPS: | $-1.020 |
FY | 2021 |
营收: | $147.79M |
毛利润: | $82.94M (56.12 %) |
EPS: | $0.290 |
Financial Reports:
No articles found.
Anika Therapeutics Inc
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。